High KLK5 expression significantly correlated with worse RFS in breast cancer with lymph node (LN) positivity, suggesting that downregulation of KLK5 may have no clinical significance in breast cancer without accurate subtyping (Supporting Information: Figure S1). The gene discussed is KLK5; the disease is breast carcinoma.